Alchemy Partners, a private equity firm, agreed to invest £100m ($141m) in DNA Payments, a payments company. “Alchemy’s investment marks a historic day for DNA and is a huge endorsement of our company and our technology. We have been looking for the right partner with the right ethos, vision and experience and we are lucky to have found this partnership with Alchemy," Arif Babayev and Nurlan Zhagiparov, DNA Payments Founders.